Bio & Pharma
Lunit exports AI imaging analysis solution to Brazil
The S. Korean startup signed a contract with Brazil's Albert Einstein Hospital, the largest general hospital in Latin America
By Dec 19, 2022 (Gmt+09:00)
1
Min read
Most Read
S.Korea's LS Materials set to boost earnings ahead of IPO process
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
Macquarie eyes its 1st Korean data center valued around $722 mn
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
Galaxy Ring, new foldables set to steal the show at Samsung Unpacked Paris
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
SK Inc. in talks to sell Pharmteco’s US CDMO plant to Novo Nordisk
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
POSCO gears up for carbon-free steelmaking with hydrogen
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
![Lunit exports AI imaging analysis solution to Brazil](https://www.kedglobal.com/data/ked/image/2022/12/19/ked202212190005.630x.0.jpg)
Einstein Hospital represents Latin America's largest hospital system, operating three general hospitals with more than 600 beds, 10 satellite hospitals and 24 outpatient centers.
Under the agreement terms, Lunit will supply Lunit Insight CXR to Einstein Hospital by 2025. The hospital plans to use the AI solution to read up to 40,000 chest X-ray images per year in its intensive care units and emergency rooms as well as in the patient examination process.
Lunit Insight CXR is an AI-based product that diagnoses 10 different chest diseases, including lung cancer and pneumothorax, with a 97% to 99% accuracy rate. The equipment was recently certified under the new European medical device regulation (MDR).
"Lunit Insight CXR will be an excellent tool to support medical staff's diagnostic decision-making. In partnership with Lunit, which possesses world-class technology, we will continue to provide quality medical services that meet all of our patient needs," said Sidney Klajner, CEO of Einstein Hospital.
"We will focus our sales effort so that the latest agreement can serve as a foothold for moving further into Latin America," said Lunit CEO Suh Beom-seok.
Write to Jung-Eun Kim at likesmile@hankyung.com
More to Read
-
Korean startupsHealthQuest-backed Lunit applies for 2022 Kosdaq IPO
Nov 30, 2021 (Gmt+09:00)
3 Min read -
Korean startupsHealthQuest picks Korea’s Lunit for first investment in Asia
Nov 24, 2021 (Gmt+09:00)
2 Min read
Comment 0
LOG IN